Health care stocks declined Thursday afternoon with the NYSE Health Care Index falling 2.2% and the Health Care Select Sector SPDR Fund (XLV) down 2.2%.
The iShares Biotechnology ETF (IBB) shed 1.3%.
In corporate news, Eli Lilly (LLY) slashed its full-year earnings outlook due to acquisition-related charges, while Q1 results surpassed market expectations. The shares slumped 10%.
Moderna's (MRNA) Q1 loss unexpectedly narrowed as a drop in expenses helped counter the decline in revenue. The stock fell 4.8%.
CVS Health (CVS) raised its full-year earnings outlook after reporting stronger-than-expected Q1 results. The shares jumped 6.3%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.